Cargando…

Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia

BACKGROUND: Activation of glial cells, including astrocytes and microglia, has been implicated in the inflammatory responses underlying brain injury and neurodegenerative diseases including Alzheimer's and Parkinson's diseases. Although cultured astrocytes and microglia are capable of resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Wenwen, Zong, Yijia, Mohammad, Arwa, Ajit, Deepa, Cui, Jiankun, Han, Dongdong, Hamilton, Jennifer L, Simonyi, Agnes, Sun, Albert Y, Gu, Zezong, Hong, Jau-Shyong, Weisman, Gary A, Sun, Grace Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206447/ https://www.ncbi.nlm.nih.gov/pubmed/21943492 http://dx.doi.org/10.1186/1742-2094-8-121

Ejemplares similares

Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation
por: Du, Huan, et al.
Publicado: (2023)

Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis
por: Li, Kaijun, et al.
Publicado: (2010)

Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA
por: Dong, Tianyi, et al.
Publicado: (2017)

Modulation of Airway Expression of the Host Bactericidal Enzyme, sPLA2-IIA, by Bacterial Toxins
por: Wu, Yongzheng, et al.
Publicado: (2023)

High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome
por: Ahmad, Nurul Saadah, et al.
Publicado: (2020)

A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells
por: Martín, Rubén, et al.
Publicado: (2017)

Inhibition of sPLA(2)-IIA Prevents LPS-Induced Neuroinflammation by Suppressing ERK1/2-cPLA(2)α Pathway in Mice Cerebral Cortex
por: Xiang, Yanxiao, et al.
Publicado: (2013)

The Roles of sPLA(2)s in Skin Homeostasis and Disease
por: Yamamoto, Kei, et al.
Publicado: (2023)

Secretory PLA(2)-IIA: a new inflammatory factor for Alzheimer's disease
por: Moses, Guna SD, et al.
Publicado: (2006)

Comparison of sPLA2IIA performance with high-sensitive CRP neutrophil percentage PCT and lactate to identify bacterial infection
por: Tan, Toh Leong, et al.
Publicado: (2021)

The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults—A systematic review
por: Tan, Toh Leong, et al.
Publicado: (2017)

Context-dependent effect of sPLA(2)-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer
por: Chovatiya, Gopal L., et al.
Publicado: (2019)

High-Density Lipoprotein (HDL) Counter-Regulates Serum Amyloid A (SAA)-Induced sPLA(2)-IIE and sPLA(2)-V Expression in Macrophages
por: Zhu, Shu, et al.
Publicado: (2016)

Alternative Targets for sPLA2 Activity: Role of Membrane-Enzyme Interactions
por: Alekseeva, Anna S., et al.
Publicado: (2023)

CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department
por: Tan, Toh Leong, et al.
Publicado: (2016)

Interactions of pharmacologically active snake venom sPLA(2) with different cell lines
por: Doumanov, Jordan, et al.
Publicado: (2014)

Hemolytic activity and platelet aggregation inhibitory effect of vipoxin's basic sPLA(2) subunit
por: Stoykova, Silviya, et al.
Publicado: (2013)

sPLA2 Wobbles on the Lipid Bilayer between Three Positions, Each Involved in the Hydrolysis Process
por: Kuzmina, Natalia, et al.
Publicado: (2022)

Prolonged exposure of cortical neurons to oligomeric amyloid-β impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (–)-epigallocatechin-3-gallate
por: He, Yan, et al.
Publicado: (2011)

Quercitrin neutralizes sPLA2IIa activity, reduces the inflammatory IL-6 level in PC3 cell lines, and exhibits anti-tumor activity in the EAC-bearing mice model
por: Sophiya, P., et al.
Publicado: (2022)

Obesity-Induced Coronary Microvascular Disease Is Prevented by iNOS Deletion and Reversed by iNOS Inhibition
por: Shah, Soham A., et al.
Publicado: (2023)

The dual role of iNOS in cancer()
por: Vannini, Federica, et al.
Publicado: (2015)

Sildenafil Ameliorates Gentamicin-Induced Nephrotoxicity in Rats: Role of iNOS and eNOS
por: Morsy, Mohamed A., et al.
Publicado: (2014)

Structure Activity Relationship and Molecular Docking of Some Quinazolines Bearing Sulfamerazine Moiety as New 3CLpro, cPLA2, sPLA2 Inhibitors
por: Hussein, Mohammed Abdalla, et al.
Publicado: (2023)

sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor
por: Pan, Yangbin, et al.
Publicado: (2014)

eNOS/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia
por: Du, L, et al.
Publicado: (2017)

Brain function in iNOS knock out or iNOS inhibited (l-NIL) mice under endotoxic shock
por: Schweighöfer, Hanna, et al.
Publicado: (2014)

The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013)

Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017)

Magnolia polyphenols attenuate oxidative and inflammatory responses in neurons and microglial cells
por: Chuang, Dennis Y, et al.
Publicado: (2013)

Cytosolic phospholipase A(2) plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway
por: Chuang, Dennis Y., et al.
Publicado: (2015)

Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
por: Anglès, O, et al.
Publicado: (2000)

Upregulation of iNOS and phosphorylated eNOS in the implantation‐induced blastocysts of mice
por: Seki, Misato, et al.
Publicado: (2023)

iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection
por: Kumar, Amod, et al.
Publicado: (2017)

Discovery of AZD2716: A Novel Secreted Phospholipase A(2) (sPLA(2)) Inhibitor for the Treatment of Coronary Artery Disease
por: Giordanetto, Fabrizio, et al.
Publicado: (2016)

Aging and Insulin Resistance: Just Say iNOS
por: Evans, Joseph L., et al.
Publicado: (2013)

Recipient iNOS but Not eNOS Deficiency Reduces Luminal Narrowing in Tracheal Allografts
por: Minamoto, Kanji, et al.
Publicado: (2002)

Expression of Inducible Nitric Oxide Synthase (iNOS) in Microglia of the Developing Quail Retina
por: Sierra, Ana, et al.
Publicado: (2014)

The return of the Scarlet Pimpernel: cobalamin in inflammation II — cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS
por: Wheatley, Carmen
Publicado: (2007)

An Evaluation of 3-Rhamnosylquercetin, a Glycosylated Form of Quercetin, against the Myotoxic and Edematogenic Effects of sPLA (2) from Crotalus durissus terrificus
por: Toyama, Daniela de Oliveira, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lojb4gmk1qejp1i3imicf7dioa